Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Infiltration of CD8+ lymphocytes is an independent prognostic factor of biochemical failure-free survival in prostate cancer.

Ness N, Andersen S, Valkov A, Nordby Y, Donnem T, Al-Saad S, Busund LT, Bremnes RM, Richardsen E.

Prostate. 2014 Oct;74(14):1452-61. doi: 10.1002/pros.22862. Epub 2014 Aug 11.

PMID:
25111810
2.

Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.

Al-Shibli KI, Donnem T, Al-Saad S, Persson M, Bremnes RM, Busund LT.

Clin Cancer Res. 2008 Aug 15;14(16):5220-7. doi: 10.1158/1078-0432.CCR-08-0133.

3.

Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer.

de Jong RA, Leffers N, Boezen HM, ten Hoor KA, van der Zee AG, Hollema H, Nijman HW.

Gynecol Oncol. 2009 Jul;114(1):105-10. doi: 10.1016/j.ygyno.2009.03.022. Epub 2009 May 2.

PMID:
19411095
4.

Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients.

Deschoolmeester V, Baay M, Van Marck E, Weyler J, Vermeulen P, Lardon F, Vermorken JB.

BMC Immunol. 2010 Apr 12;11:19. doi: 10.1186/1471-2172-11-19.

5.

Prognostic impact of lymphocytes in soft tissue sarcomas.

Sorbye SW, Kilvaer T, Valkov A, Donnem T, Smeland E, Al-Shibli K, Bremnes RM, Busund LT.

PLoS One. 2011 Jan 27;6(1):e14611. doi: 10.1371/journal.pone.0014611.

6.

Tumour-infiltrating lymphocytes: A prognostic factor of PSA-free survival in patients with local prostate carcinoma treated by radical prostatectomy.

Kärjä V, Aaltomaa S, Lipponen P, Isotalo T, Talja M, Mokka R.

Anticancer Res. 2005 Nov-Dec;25(6C):4435-8.

7.
8.

CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers.

Wakabayashi O, Yamazaki K, Oizumi S, Hommura F, Kinoshita I, Ogura S, Dosaka-Akita H, Nishimura M.

Cancer Sci. 2003 Nov;94(11):1003-9.

9.

CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma.

Fukunaga A, Miyamoto M, Cho Y, Murakami S, Kawarada Y, Oshikiri T, Kato K, Kurokawa T, Suzuoki M, Nakakubo Y, Hiraoka K, Itoh T, Morikawa T, Okushiba S, Kondo S, Katoh H.

Pancreas. 2004 Jan;28(1):e26-31.

PMID:
14707745
10.

The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma.

Wang J, Jia Y, Wang N, Zhang X, Tan B, Zhang G, Cheng Y.

J Transl Med. 2014 Jan 7;12:7. doi: 10.1186/1479-5876-12-7.

11.

The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: an immunohistochemical study of tissue microarrays.

Tewari N, Zaitoun AM, Arora A, Madhusudan S, Ilyas M, Lobo DN.

BMC Cancer. 2013 Sep 24;13:436. doi: 10.1186/1471-2407-13-436.

12.

Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients--a study of the OVCAD consortium.

Bachmayr-Heyda A, Aust S, Heinze G, Polterauer S, Grimm C, Braicu EI, Sehouli J, Lambrechts S, Vergote I, Mahner S, Pils D, Schuster E, Thalhammer T, Horvat R, Denkert C, Zeillinger R, Castillo-Tong DC.

BMC Cancer. 2013 Sep 17;13:422. doi: 10.1186/1471-2407-13-422.

13.

The prognostic value of intraepithelial and stromal CD3-, CD117- and CD138-positive cells in non-small cell lung carcinoma.

Al-Shibli K, Al-Saad S, Andersen S, Donnem T, Bremnes RM, Busund LT.

APMIS. 2010 May;118(5):371-82. doi: 10.1111/j.1600-0463.2010.02609.x.

PMID:
20477813
14.

High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma.

Rauser S, Langer R, Tschernitz S, Gais P, Jütting U, Feith M, Höfler H, Walch A.

BMC Cancer. 2010 Nov 5;10:608. doi: 10.1186/1471-2407-10-608.

15.

Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.

Huang Y, Wang FM, Wang T, Wang YJ, Zhu ZY, Gao YT, Du Z.

Digestion. 2012;86(4):329-37. doi: 10.1159/000342801. Epub 2012 Nov 28.

PMID:
23207161
16.

Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma.

Anraku M, Cunningham KS, Yun Z, Tsao MS, Zhang L, Keshavjee S, Johnston MR, de Perrot M.

J Thorac Cardiovasc Surg. 2008 Apr;135(4):823-9. doi: 10.1016/j.jtcvs.2007.10.026.

17.

[Prognostic value of T lymphocytes infiltration in breast cancer].

Yu HM, Jiao SC, Yang JL, Wang JD.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013 Apr;35(2):199-206. doi: 10.3881/j.issn.1000-503X.2013.02.013. Chinese.

18.

CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer.

Liu S, Lachapelle J, Leung S, Gao D, Foulkes WD, Nielsen TO.

Breast Cancer Res. 2012 Mar 15;14(2):R48.

19.

Inflammation in gastric adenocarcinoma of the cardia: how do EBV infection, Her2 amplification and cancer progression influence tumor-infiltrating lymphocytes?

Haas M, Büttner M, Rau TT, Fietkau R, Grabenbauer GG, Distel LV.

Virchows Arch. 2011 Apr;458(4):403-11. doi: 10.1007/s00428-011-1058-1. Epub 2011 Feb 26.

PMID:
21359545
20.

Role of stromal collagen in immunomodulation and prognosis of advanced gastric carcinoma.

Ohno S, Tachibana M, Fujii T, Ueda S, Kubota H, Nagasue N.

Int J Cancer. 2002 Feb 20;97(6):770-4.

Items per page

Supplemental Content

Write to the Help Desk